logo dark logo light logo
  • THE CAPSULE
  • TRIALS
  • KEY BENEFITS
  • NEWS
  • TEAM
  • CONTACT
logo dark logo light logo
  • THE CAPSULE
  • TRIALS
  • KEY BENEFITS
  • NEWS
  • TEAM
  • CONTACT
mobile-logo
  • THE CAPSULE
  • TRIALS
  • KEY BENEFITS
  • NEWS
  • TEAM
  • CONTACT
09 Nov

Atmo Biosciences Successfully Completes ISO 13485:2016 Audit

by Hannah Kenner
in News
Comments

Atmo Biosciences is pleased to announce that it has successfully completed the audit of its Quality Management System to obtain ISO 13485:2016 accreditation.

Continue reading
02 Nov

Atmo Biosciences and RMIT University Granted European and Australian Patents for Ingestible Gas-Sensing Capsule

by Hannah Kenner
in News
Comments

Atmo Biosciences is pleased to announce that the European Patent Office and IP Australia have each granted patents related to key intellectual property for Atmo’s ingestible gas sensor capsule, providing coverage until 2037.  

Continue reading
04 Oct

Positive Atmo Capsule Clinical Trial results published

by Hannah Kenner
in News
Comments

Atmo Biosciences is pleased to announce publication of a clinical study demonstrating strong agreement between data from Atmo’s world-first ingestible gas-sensing capsule and and a validated, FDA-cleared Wireless Motility Capsule (WMC), in determining transit metrics in healthy subjects.

Continue reading
15 Sep

Atmo Biosciences and RMIT University granted US patent for Ingestible Gas Sensor Capsule

by Hannah Kenner
in News
Comments

Atmo Biosciences is pleased to announce that the US Patent and Trademark Office (USPTO) has granted the patent for Atmo’s ingestible gas sensor capsule.

Continue reading
26 Jul

Atmo Biosciences Appoints Medical Advisory Board

by Hannah Kenner
in News
Comments
Atmo Biosciences has appointed a Medical Advisory Board (MAB), comprising world-renowned gastroenterologists.

Continue reading
Atmo board appointments
05 May

Atmo Biosciences strengthens executive leadership team and Board of Directors

by Hannah Kenner
in News
Comments

Atmo Biosciences Limited, a digital health company developing the world’s first ingestible gas-sensing capsule for monitoring gut health and microbiome function, has made three key appointments, further building capability at the executive and Board levels.

Continue reading
Atmo Biosciences CEO Mal Hebblewhite with gas-sensing capsule
23 Sep

Atmo Biosciences secures $9.6 million in oversubscribed capital raise

by atmobio
in News
Comments

Atmo Biosciences has closed a successful, oversubscribed A$9.6m capital raise.

The raise was led by two new, cornerstone investors – Sydney-based investment firm Alium Capital Management and Japanese multinational company Otsuka Pharmaceutical.

Continue reading
Atmo Biosciences CEO Mal Hebblewhite speaks to Medical Director
21 Sep

Atmo featured on Medical Director’s Healthtech Showcase

by atmobio
in News
Comments

Atmo Biosciences CEO Mal Hebblewhite was invited to present at Medical Director’s Healthtech Showcase.

Continue reading
Poster showing Atmo Gas Capsule can be used to assess regional gastrointestinal transit in healthy adults
09 Sep

Study results presented at AGW show Atmo Gas Capsule can be used to assess regional gastrointestinal transit in healthy adults

by atmobio
in News
Comments

A Monash University comparative study has found Atmo Biosciences’ novel ingestible gas-sensing capsule to be similar to a validated wireless motility capsule (WMC) when assessing regional gastrointestinal transit time in healthy adults.

Continue reading
Atmo Biosciences software
29 Jul

Atmo Biosciences awarded Victorian Government Technology Adoption and Innovation Program grant to support software development

by atmobio
in News
Comments

Atmo Biosciences has been awarded a Victorian Government Technology Adoption and Innovation Program (TAIP) grant to support the software development for the Atmo Gas Capsule.

Continue reading
  • 1
  • 2
  • 3
email

info@atmobiosciences.com
Australia - VIC

436 Elgar Rd
Box Hill VIC 3128
Australia - NSW

6 Middlemiss St
Lavender Bay NSW 2060

© Atmo Biosciences

Partner

Privacy Policy